[HTML][HTML] Overview of the pathogenesis of COVID‑19
C Li, Q He, H Qian, J Liu - … and Therapeutic Medicine, 2021 - spandidos-publications.com
At present, the pathogenesis of the novel coronavirus disease 2019 (COVID‑19) has not
been fully elucidated. Clinical and experimental findings from studies investigating COVID …
been fully elucidated. Clinical and experimental findings from studies investigating COVID …
Immunology, immunopathogenesis and immunotherapeutics of COVID-19; an overview
LM Khosroshahi, M Rokni, T Mokhtari… - International …, 2021 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) infection which is caused by severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2) has led to a “public health emergency of …
respiratory syndrome coronavirus-2 (SARS-CoV-2) has led to a “public health emergency of …
[HTML][HTML] COVID-19: The emerging immunopathological determinants for recovery or death
Hyperactivation of the host immune system during infection by SARS-CoV-2 is the leading
cause of death in COVID-19 patients. It is also evident that patients who develop …
cause of death in COVID-19 patients. It is also evident that patients who develop …
COVID-19 as an acute inflammatory disease
RH Manjili, M Zarei, M Habibi… - The journal of immunology, 2020 - journals.aai.org
Abstract The 2019 coronavirus disease (COVID-19) pandemic caused by the virus severe
acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has created an unprecedented …
acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has created an unprecedented …
COVID‐19 immunopathology: from acute diseases to chronic sequelae
The clinical manifestation of coronavirus disease 2019 (COVID‐19) mainly targets the lung
as a primary affected organ, which is also a critical site of immune cell activation by severe …
as a primary affected organ, which is also a critical site of immune cell activation by severe …
[HTML][HTML] Immune response, inflammation, and the clinical spectrum of COVID-19
LF García - Frontiers in immunology, 2020 - frontiersin.org
The current COVID-19 pandemic began in December 2019 in Wuhan (China) and rapidly
extended to become a global sanitary and economic emergency. Its etiological agent is the …
extended to become a global sanitary and economic emergency. Its etiological agent is the …
[HTML][HTML] Severe COVID-19: what have we learned with the immunopathogenesis?
B Bordallo, M Bellas, AF Cortez, M Vieira… - Advances in …, 2020 - SciELO Brasil
The COVID-19 outbreak caused by severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) has become a global major concern. In this review, we addressed a theoretical …
CoV-2) has become a global major concern. In this review, we addressed a theoretical …
[HTML][HTML] Immunologic features in coronavirus disease 2019: functional exhaustion of T cells and cytokine storm
To the Editor: Since the emergence of Coronavirus Disease 2019 (COVID-19) caused by the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in December 2019, the …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in December 2019, the …
Clinical characteristics and immune injury mechanisms in 71 patients with COVID-19
Y Wu, X Huang, J Sun, T Xie, Y Lei, J Muhammad, X Li… - Msphere, 2020 - Am Soc Microbiol
The outbreak of coronavirus disease 2019 (COVID-19), caused by the novel coronavirus
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused a threat to …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused a threat to …
Tackling the cytokine storm in COVID-19, challenges and hopes
The outbreak of Coronavirus disease 2019 (COVID-19) is the current world health concern,
presenting a public health dilemma with ascending morbidity and mortality rates exceeding …
presenting a public health dilemma with ascending morbidity and mortality rates exceeding …